GlassScriptPhysician profile
Richard Alan Bennett
NPI 1801894431
$1,662.84
in general payments reported to CMS, 2019-2025
24 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $167 · 2021: $156 · 2022: $211 · 2023: $197 · 2024: $402 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $311.65 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Aspira Women'S Health INC | $171.62 | 2022-2024 | Ova1 |
| Astellas Pharma US INC | $146.08 | 2023-2025 | Veozah, Myrbetriq |
| Avion Pharmaceuticals | $120.29 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $119.77 | 2025 | |
| Organon LLC | $118.12 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $72.92 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $65.40 | 2024 | Novasure, Aptima |
| Biogen, INC. | $64.30 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $60.60 | 2024-2025 | Gemtesa, Myfembree |
| Allergan, INC. | $59.18 | 2020-2022 | |
| Olympus America INC. | $54.88 | 2019-2022 | |
| Shield Therapeutics INC | $48.74 | 2024 | |
| Coopersurgical, INC. | $45.13 | 2023-2024 | Endosee, Summit Doppler |
| Amarin Pharma, INC. | $40.01 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $35.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.07 | 2025 | |
| Sanofi Pasteur INC. | $19.83 | 2025 | |
| Roche Diagnostics Corporation | $16.89 | 2019 | |
| Kci USA, INC. | $14.42 | 2021 | |
| Boston Scientific Corporation | $13.97 | 2025 | Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Merck Sharp & Dohme LLC | $13.78 | 2019 | |
| Pfizer INC. | $13.39 | 2024 | |
| Minerva Surgical, INC | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.